 Here using drug susceptibility profiling, genomics and evolutionary studies the authors provide strategies to exploit collateral drug responses in mycobacterium tuberculosis to prevent the emergence of drug resistance. This article was authored by Natalie J. E. Waller, Jenny Chum, Gregory M. Cook, and others.